Paola Queirolo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib (NCT01983124) | Paola Queirolo | 2013-02-01 |
Track Paola Queirolo automatically
Every clearance here is in the API, with alerts when new ones post.